Over 100 volunteers in Melbourne and Brisbane will take part in phase one of a human trial for a potential coronavirus vaccine.
The trails are being handled by Novavax, a US biotechnology company and will take place in both cities with 132 healthy adults between ages 18 and 59 years.
Dr Paul Griffin, Infectious diseases expert at Mater Health Services Brisbane, is overseeing the phase one clinical trials, a first step in human testing.
"It's very exciting," he said on Nina's Today show.
"Healthy volunteers will receive this vaccine for the first time and it's predominantly about safety. So we will carefully monitor them throughout."
Novavax expects to share results in July which could lead to phase two trials, looking at how the vaccine affects people with coronavirus and side effects.